Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneous disease caused by several gene
mutations and cytogenetic abnormalities affecting differentiation and proliferation of myeloid …
mutations and cytogenetic abnormalities affecting differentiation and proliferation of myeloid …
FLT3LG-a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin
The fms-related tyrosine kinase 3 (FLT3) ligand (FLT3LG) binds to FLT3 on dendritic cells to
stimulate their differentiation and expansion, hence facilitating tumor antigen cross …
stimulate their differentiation and expansion, hence facilitating tumor antigen cross …
Mechanism of Drug Tolerance in FLT3 Mutant Acute Myeloid Leukemia
M Gebru - 2020 - etda.libraries.psu.edu
AML is a heterogeneous disease caused by several mutations and cytogenetic
abnormalities affecting differentiation and proliferation of myeloid lineage cells. FLT3 is a …
abnormalities affecting differentiation and proliferation of myeloid lineage cells. FLT3 is a …